[Pseudomonas spp. infections in patients with HIV infections]. 1996

A Payeras, and M Riera, and M Riera, and J Altés, and F Homar, and J Gil, and A Salas, and C Villalonga
Unidad de Enfermedades Infecciosas, Hospital Son Dureta, Palma de Mallorca.

BACKGROUND The aim of this study was to describe the characteristics of the infections by Pseudomonas spp. observed in patients with HIV infection in Spain. METHODS A retrospective study was performed of the isolations of Pseudomonas spp. in microbiologic samples of patients with HIV infection in three hospitals from Mallorca, Spain, since 1986. RESULTS Twenty-nine patients with some positive culture for Pseudomonas were reviewed. In 20 cases the infection presented in advanced stages of the disease when the patient fulfilled AIDS criteria. The most frequent foci in both community acquired and nosocomial infection was respiratory (16 and 3 cases, respectively). Fifty percent of the cases presented bacteremia. The classically described predisposing factors for infection by this germ were presented in 19 patients. Pseudomonas aeruginosa was the most frequently isolated type (22 cases). Only 5 patients received the appropriate treatment on admission. Clinical cure was achieved in 23 patients, with recurrence being observed in 10. Five patients died in relation to the infection. CONCLUSIONS Infections by Pseudomonas spp. in Spain appear to have increased in frequency in patients with HIV infection in the last decade. These infections appear in advanced phases of the disease and mainly involve the lung, with high rates of bacteremia and a high number of recurrence. Empiric treatment of patients with advanced HIV infection with suspicion of bacterial infection should include antipseudomonic drugs.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013030 Spain Country located between France on the northeast and Portugal on the west and bordered by the Atlantic Ocean and the Mediterranean Sea. The capital is Madrid. Balearic Islands,Canary Islands
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

A Payeras, and M Riera, and M Riera, and J Altés, and F Homar, and J Gil, and A Salas, and C Villalonga
February 2000, European journal of epidemiology,
A Payeras, and M Riera, and M Riera, and J Altés, and F Homar, and J Gil, and A Salas, and C Villalonga
October 1995, Genitourinary medicine,
A Payeras, and M Riera, and M Riera, and J Altés, and F Homar, and J Gil, and A Salas, and C Villalonga
March 1984, Antimicrobial agents and chemotherapy,
A Payeras, and M Riera, and M Riera, and J Altés, and F Homar, and J Gil, and A Salas, and C Villalonga
July 1983, The Journal of antimicrobial chemotherapy,
A Payeras, and M Riera, and M Riera, and J Altés, and F Homar, and J Gil, and A Salas, and C Villalonga
February 1997, Presse medicale (Paris, France : 1983),
A Payeras, and M Riera, and M Riera, and J Altés, and F Homar, and J Gil, and A Salas, and C Villalonga
March 1986, International journal of clinical pharmacology, therapy, and toxicology,
A Payeras, and M Riera, and M Riera, and J Altés, and F Homar, and J Gil, and A Salas, and C Villalonga
May 2010, International journal of antimicrobial agents,
A Payeras, and M Riera, and M Riera, and J Altés, and F Homar, and J Gil, and A Salas, and C Villalonga
February 1997, Behring Institute Mitteilungen,
A Payeras, and M Riera, and M Riera, and J Altés, and F Homar, and J Gil, and A Salas, and C Villalonga
April 1978, Meditsinskaia sestra,
A Payeras, and M Riera, and M Riera, and J Altés, and F Homar, and J Gil, and A Salas, and C Villalonga
January 1999, Journal of the Royal College of Physicians of London,
Copied contents to your clipboard!